Home  |  News  |  Sitemap  |  Contact Us  |  Login
Advertise With Us
Latest Notification
  • banner1
  • banner2
  • banner3
  • banner4
  • banner5
  • banner6
  • banner7
banner11 banner22 banner33 banner44 banner45 banner46 banner47

 Case Digest


Back
Drugs and Cosmetics Act, 1940
Search:  
Please select section
Section 18-Presumption of Sale
Section 27 (b) (ii) and 27 (b) - Conviction under - Challenged in the present petition
Petition under
Sections 27(b)(ii) and 28-Conviction under - by the Chief Judicial Magistrate Ferozepur
Section 18 (c), 18-A and 22 (11) (cc)--seeking quashing of the proceedings in c.c. No. 36/2011
Section 32—No bar under the Act against launching prosecution on the basis of the FIR lodged
Section 28-B—Framing of the charge under
Sections 17B, 18 (a)(i), 18 (c), Sections 27 (a)/27(b)(ii), 28/27(c) –IPC, 1860—Sections 420/468/34—Cognizance taken against the petitioner under—in challenge
Section 33 EEC (C) and 33 EEC (A) (i)—appeal filed for enhancement of sentence
Section 26-A—Ban order
Section 27—FIR registered under
Section 34, Rule 66—application of the provisions of – drug licence—cancellation of – appeal filed
Section 25—application of the provision of
Section 18 (a) (i), 27 (d)—Prima facie allegations showed that the Directors (accused No. 2 to 8 ) of the accused No. 1 -Company were also responsible for the manufacture of the drug
Section 27 (11) (6)—Indian Penal Code, 1860—Sections 413/414—Bail application rejected
Sections 27 (d), 18 (a)(i), 18 (a)(vi), 18 (c)—cognizance taken for violation of the provisions of—appeal against—Rules 75A, 96, 97, Section 17 (b)
Section 17-B, (d), (e), 18 (i) (c)—IPC , 1860—Section 468—MCOCA, 1999—Section 3 (i) (ii)—conviction and sentence for commission of the offences under—appeal against
Section 26-A, 5—ban on the use of drug Phenylpropanolamine (PPA)— by impugned Notification—in challenge—whether the prohibition is violative of Article 19 (1)(g) of the constitution of India—yes
Section 25 (3)—application under
Section 22 (3), 28—Conviction and sentence under—in challenge
Section 18 (A) (6) r/w Rule 65 (18) and Section 27 (d)—conviction under
Section 32 — Prosecution of the petitioner under
Section 25 (3)—right for getting the sample retested
Section 27—IPC, 1860—Sections 120B, 420, 468, 469—issuance of process under—application filed—for quashing the said order
Sections 27 (c), 27 (d)—Non-examination of the independent witness does not create any dent on the case of the prosecution
Section 18 (a) (vi) r/w Rule 65 (17)—“Physician’s Sample not to be sold” for public sale
Section 33-M—Sanction
Sections 27 (c), 27 (d)—No public Analyst was examined
Sections 27(b)(ii), 18 Rule 123—Dettol is a ‘Disinfectant’
Sections 27 (b) (i), 27 (c), 27 (d), 27 (b)(ii), 28-A and 22 (3)
Section 22 and Rule 106B-Constitution of India, 1950- Article 226 - petition under - for issuance of a writ of Mandamus to forbear the respondents and their subordinate officials from interfering with the right of the petitioner to keep homeopathic dilutions in 500 milliliters pound pack
Section 22 and 23-Powers of Inspectors
Sections 27(a), 27(d), 28(a) and 28(b) - respondents discharged
Sections 3 (b) and 18 (c)- Article is a drug or not?
Section 25(3)-Analyst's report-Not in prescribed form-lf admissible
Section 17/17A/17B/18/27-FIR under-Petition for quashing of
Section 27 (d) and 27 (d)(2)- conviction under-revisional jurisdiction does not empower re-appreciation of evidence
Section 26-A - Banning the use of Quinacrine as a method of female sterilization
Section 27 (b)(ii)-conviction under -the petitioner has been unable to disclose the source of acquisition of allopathic drugs mentioned in seizure memo
Section 26, Rule 65(5)(3)-Violations
Section 25 (4)-Exercise of right under
Sections 18(c) read with section 27(b)(ii) -conviction under
Sections 18(c) read with section 27(b)(ii) - complaint under
Section 12 and 18 (1)(c)-Drugs and Cosmetics Rules, 1945-Rule 2(ee)-Charge under-for sale of drugs without licence-petitioner not qualified to prescribe allopathic medicines
Sections 18 (a)(i) and 27 (d) and 34-Complaint under-No averment in the complaint
Sections 18, 18 (a)(i) read with Section 17B(d)-sections 21 and 32-jurisdiction to launch prosecution under Section 32 of the Act
Section 18-A, 27 and 28-prosecution under
Sections 18 and 23-Pharmacy Act, 1948-Section 32 (2)-NDPS Act, 1985- Section 22-Narcotic Drugs and Psychotropic Substances Rules, 1985-Rule 66
Sections 18 and 27—charge under
Section 18 (a) (i) (ii), (iia), 27 (a) (i) , 27 (b) and Rule 46 and Rule 65 (18)—Appeal against acquittal
Section 18 (1) and 18 (c)—Boric Acid—Samples taken
Section 17B, 27A, 18-A, 18-B, 28 and 28-A—framing of charges against the petitioners—spurious drugs manufactured prior to transfer of business
Section 18 (a) (i) read with section 27 (d) and 27 (c)—offence under
Sections 21, 32 and 33-G--Jurisdiction of the Drugs Inspector appointed under section 21 of the Drugs and Cosmetics Act
Section 3 (h)—Patent and proprietary medicines
Section 27 (B) (ii)—possession of medicine without having valid licence
Section 3 (B) and 18--Drugs--Absorbent cotton wool, roller bandages and gauze-- Whether drugs
Section 25(4) and 34(1) violation of
Sections 21, 33-EEC and G--Jurisdction of Drugs Inspector in case of manufacture and sale of ayurvedic drugs
Sections 20, 21--Non-compliance of
Sections 18 (a) (1), 18A, 23 (4), 25 and 27--Mandatory provisions--duly complied with--Criminal Procedure Code, 1973-- Sections 482
Sections 16 (1) a, 17 C, 17 B (d) read with Sections 27 (a) and 27 (b)--Charge Under—Cetrizine drug seized from petitioners—in the complaint it is no where mentioned that the drug was found sub-standard on analysis
Section 3 (b)--Patent and proprietary medicines - license to manufacture--granting of
Section 27, 27-A (i) and (ii), 28 read with Section 18--No evidence to show that the petitioner had any shop or he was selling the drugs
Section 27(a) and (d)--Essential ingredients of the offences are not made out in the complaint
Section 32--Complaint filed after expiry of Shelf Life of drug
Section 23, 25--Suspended article found in a bottle of Crocin Syrup, by Drugs Inspector—for analysis bottle not sent
Section 18 and 27—Maintainability of the charge—identification of the sample not established
Section 27 (a) and (b)—Scope of—Supply of drugs to the Drugs Inspector is sale of drugs in the eye of law
Sections 19(2) (b) and 27—quashing of complaint –drug contaminated with fungus
Sections 33-EEC(c) – appeal against conviction – plea bargaining
Sections 27(b) (ii) and 28—Narcotic Drugs and Psychotropic Substances Act, 1985—Sections 8, 22 and 23—petitioners holding a valid drug licence and a Certificate of Import and Export
Sections 23(4) and 25--Shelf life of drug had expired—-applicants deprived of their right to get sample retested
Sections 3(e), 5, 20(1) and (2) and 68A—Drugs and Cosmetics Rules, 1945—Rules 122F, 122M and 122O and Form 27C--Jurisdiction of Licensing Authority
Investigation under - investigation against a pharmaceutical company transferred to Central Vigilance Commission (CVC)
Sections 18 and 25--Scope of--the shelf life of Gentamycin had expired much before the complaint was filed in Court
Sections 21, 22 and 23-Powers of Drugs Inspector
Section 25(4)-Reports of Government Analyst etc.
Section 25(4)-Reports of Government Analyst etc.
Section 25 (4)-Reports of Government Analyst etc
Section 27 (a) and (b) read with section 18 (a)(1)(ii)
Section 18, 27 and 28
Section 27-Penalty for manufacture, Sale etc., of drugs in contravention to Chapter IV of Act
Section 27-Penalty for manufacture, Sale etc., of drugs in contravention to Chapter IV of Act
Section 32-Cognizance of Offences
Section 33-C
Section 34- Offences by companies
Section 34- Offences by companies
Section 34- Offences by companies
Section 23-Can the Drugs Inspector send sample directly to the Central Drug Laboratory?
Section 28-Penalty for non-disclosure of the name of the manufacturer, etc.
Section 28-Penalty for non-disclosure of the name of the manufacturer, etc.
Section 34-Offence by Companies-
Section 34-Offence by Companies-
Section 34-Offence by Companies-
Section 25(3) and (4)-- Statutory right of the petitioner -– lapsed--
Section 32-Cognizance of offences
Section 27-Penalty for manufacture, Sale etc.
Section 27- Penalty for manufacture, Sale etc.
Section 18, 27 and 28
Section 27 (a) and (b) read with section 18 (a)(1)(ii)
Section 25(4). Reports of Government Analyst etc.
Section 25(4). Reports of Government Analyst etc.
Section 25(4). Reports of Government Analyst etc.
Section 23(4)(iii). Procedure of Inspector etc.
Section 22(1)(c) (iii) Order prohibiting disposal of certain drugs
Section 22(1)(c) (i) search or seizure by a Drugs Inspector
Section 18-A. Disclosure of the name of the manufacturer, etc.
Section 18-A. Disclosure of the name of the manufacturer, etc.
Section 18-A. Disclosure of the name of the manufacturer, etc.
Section 18-A. Disclosure of the name of the manufacturer, etc.
Section 18-A. Disclosure of the name of the manufacturer, etc.
Section 18-A. Disclosure of the name of the manufacturer, etc.
S.18-A. Disclosure of the name of the manufacturer, etc.
Section 18-A. Disclosure of the name of the manufacturer, etc.
Section 8(1)(j)- Investigation officer and privacy
Section 18(c) r/w Schedule ‘K’ Entry 5 - Exemption to the Registered Medical Practitioners
Section 18(c) r/w Schedule ‘K’ Entry 5 - Exemption to the Registered Medical Practitioners
Section 18(c) r/w Schedule ‘K’ Entry 5 - Exemption to the Registered Medical Practitioners
Section 18(c) r/w Schedule ‘K’ Entry 5 - Exemption to the Registered Medical Practitioners 
Section 18(c) r/w Schedule K. entry 5A
Section 18(c) r/w Schedule K. entry 5A
Section 18(c) r/w Section 27(a)(ii)
Section 18(c) r/w Section 27(a)(ii)
Section 18(c) r/w Section 27(a)(ii)
Section 5(2)-Other Officers
Section 18(c) r/w Section 27(a)(ii)
Section 5(2)-PIO
Section 18(c) r/w Section 27(a)(ii)
Section 18(c), 22(1) and (3)
Section 18(c)-Prohibition of manufacture and Sale of Certain drugs
Section 18(c)-Prohibition of manufacture and Sale of Certain drugs
Section 18(c)-Prohibition of manufacture and Sale of Certain drugs
Section 18(c)-Prohibition of manufacture and Sale of Certain drugs
Section 2(j)-“right to information”
Section 18(c)
Section 18(c) r/w Rule 62
Section 18(c) r/w Rule 62
Section 18-Prohibition of manufacture and Sale of Certain drugs
Section 17B, 18 and 19
Section 17-Misbranded drugs
Section 17
Section 17-Misbranded drugs
Section 16-Standards of Quality
Section 16, 17A, 17B, 27 and 32—18(a) (1), 25 and Drugs & Cosmetics Rules, 1945—Rules 4 and 8
Section 5(2)--- Drugs & Cosmetics Rules, 1945---Rule 106-B
Section 3(b)(i)(iii) and 18 - definition of 'drug'
Section 3- Human Blood

Back


» Home
» Latest Notification
» New Drugs
» Import of Drugs
» Drug Prices
» Legislations
» Applications Forms
» Quackwatch
» Forms & Fees
» Licence Conditions
» Schedules
» Health, Pharma. Policies & Reports
» Ayurvedic
» Govt. Bodies
» Information Centre
» Directory
» Alert
» Regulatory News
» Research News
» News in Hindi
» Login
» Contact Us

Copyright © DrugsControl.org - Jaipur, INDIA. All Rights Reserved   |   Disclaimer   |   Sitemap

Site last updated: December 30, 1899 at